Welcome to the XXXX Roadmap
- About PKAN
- Causes & Risk Factors
- Treatment & Management
- Academic & Research Institutions
- Non-Profit Support
- Private Support Groups
- Events, Runs & Walks
- Current Research
- Case Study Links
- Clinical Trials
- Journals and Med Publications
- Links We
- Video Resources
Pantothenate Kinase-Associated Neurodegeneration (PKAN), a form of Neurodegeneration. Neurodegeneration with Brain Iron Accumulation (NBIA) develops when iron accumulates in the brain resulting in nerve damage and other debilitating symptoms. PKAN is the most common form of NBIA and 30 to 50% of MBIA patients are diagnosed with PKAN.
Also referred to as:
- Hallervorden-Spatz Syndrome
- neurodegeneration with brain iron accumulation type 1
- Pigmentary Degeneration of Globus Pallidus, Substantia Nigra, Red Nucleus
Looking for the PKAN My Med Team Social Network?
Click on the graphic below.
Symptoms include dystonia, dysarthria, rigidity, spasticity, hyperreflexia and extensor toe signs
Symptoms typically begin in childhood and are progressive, often resulting in death by early adulthood. Symptoms of PKAN begin before middle childhood, and most often are noticed before ten years of age. Symptoms include:
- dystonia (repetitive uncontrollable muscle contractions that may cause jerking or twisting of certain muscle groups)
- dysphagia & dysarthria due to muscle groups involved in speech being involved
- rigidity/stiffness of limbs
- writhing movements
- seizures (rare)
- toe walking
- retinitis pigmentosa, another degenerative disease that affects the individual’s retina, often causing alteration of retinal color and progressive deterioration of the retina at first causing night blindness and later resulting in a complete loss of vision
PKAN affects one in 1 million people and is caused by genetic defects.
PKAN is inherited and is called an autosomal recessive disorder.
Eye of the Tiger